Copyright Reports & Markets. All rights reserved.

Global Gene Therapy Medicine Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Gene Therapy Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Oral
    • 1.2.3 Injection
  • 1.3 Market by Application
    • 1.3.1 Global Gene Therapy Medicine Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Cancer
    • 1.3.3 Monogenic
    • 1.3.4 Infectious Disease
    • 1.3.5 Cardiovascular Disease
    • 1.3.6 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Gene Therapy Medicine Market Perspective (2016-2027)
  • 2.2 Gene Therapy Medicine Growth Trends by Regions
    • 2.2.1 Gene Therapy Medicine Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Gene Therapy Medicine Historic Market Share by Regions (2016-2021)
    • 2.2.3 Gene Therapy Medicine Forecasted Market Size by Regions (2022-2027)
  • 2.3 Gene Therapy Medicine Industry Dynamic
    • 2.3.1 Gene Therapy Medicine Market Trends
    • 2.3.2 Gene Therapy Medicine Market Drivers
    • 2.3.3 Gene Therapy Medicine Market Challenges
    • 2.3.4 Gene Therapy Medicine Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Gene Therapy Medicine Players by Revenue
    • 3.1.1 Global Top Gene Therapy Medicine Players by Revenue (2016-2021)
    • 3.1.2 Global Gene Therapy Medicine Revenue Market Share by Players (2016-2021)
  • 3.2 Global Gene Therapy Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Gene Therapy Medicine Revenue
  • 3.4 Global Gene Therapy Medicine Market Concentration Ratio
    • 3.4.1 Global Gene Therapy Medicine Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Medicine Revenue in 2020
  • 3.5 Gene Therapy Medicine Key Players Head office and Area Served
  • 3.6 Key Players Gene Therapy Medicine Product Solution and Service
  • 3.7 Date of Enter into Gene Therapy Medicine Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy Medicine Breakdown Data by Type

  • 4.1 Global Gene Therapy Medicine Historic Market Size by Type (2016-2021)
  • 4.2 Global Gene Therapy Medicine Forecasted Market Size by Type (2022-2027)

5 Gene Therapy Medicine Breakdown Data by Application

  • 5.1 Global Gene Therapy Medicine Historic Market Size by Application (2016-2021)
  • 5.2 Global Gene Therapy Medicine Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Gene Therapy Medicine Market Size (2016-2027)
  • 6.2 North America Gene Therapy Medicine Market Size by Type
    • 6.2.1 North America Gene Therapy Medicine Market Size by Type (2016-2021)
    • 6.2.2 North America Gene Therapy Medicine Market Size by Type (2022-2027)
    • 6.2.3 North America Gene Therapy Medicine Market Size by Type (2016-2027)
  • 6.3 North America Gene Therapy Medicine Market Size by Application
    • 6.3.1 North America Gene Therapy Medicine Market Size by Application (2016-2021)
    • 6.3.2 North America Gene Therapy Medicine Market Size by Application (2022-2027)
    • 6.3.3 North America Gene Therapy Medicine Market Size by Application (2016-2027)
  • 6.4 North America Gene Therapy Medicine Market Size by Country
    • 6.4.1 North America Gene Therapy Medicine Market Size by Country (2016-2021)
    • 6.4.2 North America Gene Therapy Medicine Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Gene Therapy Medicine Market Size (2016-2027)
  • 7.2 Europe Gene Therapy Medicine Market Size by Type
    • 7.2.1 Europe Gene Therapy Medicine Market Size by Type (2016-2021)
    • 7.2.2 Europe Gene Therapy Medicine Market Size by Type (2022-2027)
    • 7.2.3 Europe Gene Therapy Medicine Market Size by Type (2016-2027)
  • 7.3 Europe Gene Therapy Medicine Market Size by Application
    • 7.3.1 Europe Gene Therapy Medicine Market Size by Application (2016-2021)
    • 7.3.2 Europe Gene Therapy Medicine Market Size by Application (2022-2027)
    • 7.3.3 Europe Gene Therapy Medicine Market Size by Application (2016-2027)
  • 7.4 Europe Gene Therapy Medicine Market Size by Country
    • 7.4.1 Europe Gene Therapy Medicine Market Size by Country (2016-2021)
    • 7.4.2 Europe Gene Therapy Medicine Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Gene Therapy Medicine Market Size (2016-2027)
  • 8.2 Asia-Pacific Gene Therapy Medicine Market Size by Type
    • 8.2.1 Asia-Pacific Gene Therapy Medicine Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Gene Therapy Medicine Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Gene Therapy Medicine Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Gene Therapy Medicine Market Size by Application
    • 8.3.1 Asia-Pacific Gene Therapy Medicine Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Gene Therapy Medicine Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Gene Therapy Medicine Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Gene Therapy Medicine Market Size by Region
    • 8.4.1 Asia-Pacific Gene Therapy Medicine Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Gene Therapy Medicine Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Gene Therapy Medicine Market Size (2016-2027)
  • 9.2 Latin America Gene Therapy Medicine Market Size by Type
    • 9.2.1 Latin America Gene Therapy Medicine Market Size by Type (2016-2021)
    • 9.2.2 Latin America Gene Therapy Medicine Market Size by Type (2022-2027)
    • 9.2.3 Latin America Gene Therapy Medicine Market Size by Type (2016-2027)
  • 9.3 Latin America Gene Therapy Medicine Market Size by Application
    • 9.3.1 Latin America Gene Therapy Medicine Market Size by Application (2016-2021)
    • 9.3.2 Latin America Gene Therapy Medicine Market Size by Application (2022-2027)
    • 9.3.3 Latin America Gene Therapy Medicine Market Size by Application (2016-2027)
  • 9.4 Latin America Gene Therapy Medicine Market Size by Country
    • 9.4.1 Latin America Gene Therapy Medicine Market Size by Country (2016-2021)
    • 9.4.2 Latin America Gene Therapy Medicine Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Gene Therapy Medicine Market Size (2016-2027)
  • 10.2 Middle East & Africa Gene Therapy Medicine Market Size by Type
    • 10.2.1 Middle East & Africa Gene Therapy Medicine Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Gene Therapy Medicine Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Gene Therapy Medicine Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Gene Therapy Medicine Market Size by Application
    • 10.3.1 Middle East & Africa Gene Therapy Medicine Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Gene Therapy Medicine Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Gene Therapy Medicine Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Gene Therapy Medicine Market Size by Country
    • 10.4.1 Middle East & Africa Gene Therapy Medicine Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Gene Therapy Medicine Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Bluebird Bio
    • 11.1.1 Bluebird Bio Company Details
    • 11.1.2 Bluebird Bio Business Overview
    • 11.1.3 Bluebird Bio Gene Therapy Medicine Introduction
    • 11.1.4 Bluebird Bio Revenue in Gene Therapy Medicine Business (2016-2021)
    • 11.1.5 Bluebird Bio Recent Development
  • 11.2 Sangamo
    • 11.2.1 Sangamo Company Details
    • 11.2.2 Sangamo Business Overview
    • 11.2.3 Sangamo Gene Therapy Medicine Introduction
    • 11.2.4 Sangamo Revenue in Gene Therapy Medicine Business (2016-2021)
    • 11.2.5 Sangamo Recent Development
  • 11.3 Spark Therapeutics
    • 11.3.1 Spark Therapeutics Company Details
    • 11.3.2 Spark Therapeutics Business Overview
    • 11.3.3 Spark Therapeutics Gene Therapy Medicine Introduction
    • 11.3.4 Spark Therapeutics Revenue in Gene Therapy Medicine Business (2016-2021)
    • 11.3.5 Spark Therapeutics Recent Development
  • 11.4 Dimension Therapeutics
    • 11.4.1 Dimension Therapeutics Company Details
    • 11.4.2 Dimension Therapeutics Business Overview
    • 11.4.3 Dimension Therapeutics Gene Therapy Medicine Introduction
    • 11.4.4 Dimension Therapeutics Revenue in Gene Therapy Medicine Business (2016-2021)
    • 11.4.5 Dimension Therapeutics Recent Development
  • 11.5 Avalanche Bio
    • 11.5.1 Avalanche Bio Company Details
    • 11.5.2 Avalanche Bio Business Overview
    • 11.5.3 Avalanche Bio Gene Therapy Medicine Introduction
    • 11.5.4 Avalanche Bio Revenue in Gene Therapy Medicine Business (2016-2021)
    • 11.5.5 Avalanche Bio Recent Development
  • 11.6 Celladon
    • 11.6.1 Celladon Company Details
    • 11.6.2 Celladon Business Overview
    • 11.6.3 Celladon Gene Therapy Medicine Introduction
    • 11.6.4 Celladon Revenue in Gene Therapy Medicine Business (2016-2021)
    • 11.6.5 Celladon Recent Development
  • 11.7 Vical Inc.
    • 11.7.1 Vical Inc. Company Details
    • 11.7.2 Vical Inc. Business Overview
    • 11.7.3 Vical Inc. Gene Therapy Medicine Introduction
    • 11.7.4 Vical Inc. Revenue in Gene Therapy Medicine Business (2016-2021)
    • 11.7.5 Vical Inc. Recent Development
  • 11.8 Advantagene
    • 11.8.1 Advantagene Company Details
    • 11.8.2 Advantagene Business Overview
    • 11.8.3 Advantagene Gene Therapy Medicine Introduction
    • 11.8.4 Advantagene Revenue in Gene Therapy Medicine Business (2016-2021)
    • 11.8.5 Advantagene Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Gene Therapy Medicine Scope and Market Size
    Gene Therapy Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Oral
    Injection

    Segment by Application
    Cancer
    Monogenic
    Infectious Disease
    Cardiovascular Disease
    Other

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Bluebird Bio
    Sangamo
    Spark Therapeutics
    Dimension Therapeutics
    Avalanche Bio
    Celladon
    Vical Inc.
    Advantagene

    Buy now